| UHC Medicaid Medical & Drug | Self-Administered Medications – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Simponi Aria® (Golimumab) Injection for Intravenous Infusion – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Somatostatin Analogs – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Subcutaneous Implantable Naltrexone Pellets – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Synagis® (Palivizumab) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Tepezza® (Teprotumumab-Trbw) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Tezspire® (Tezepelumab-Ekko) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Uplizna® (Inebilizumab-Cdon) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Vyjuvek® (Beramagene Geperpavec-Svdt) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Xiaflex® (Collagenase Clostridium Histolyticum) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |